Product Description: Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA)-approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection[1].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]Saxena D, et al. Atoltivimab/maftivimab/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus. Drugs Today (Barc). 2021 Aug;57(8):483-490.
CAS Number: 2135632-36-7
Molecular Weight: N/A
Compound Purity: 96.29
Research Area: Infection
Solubility: 10 mM in DMSO
Target: Filovirus